Insilico

News

Insilico adds Servier to partnership roster with $888m deal

Insilico has added to its partnerships list with an $888m cancer-focused alliance with Servier, just days after completing its long-awaited IPO.

News

Insilico ends 2025 with $293m Hong Kong IPO

One of the pioneers in AI-powered drug discovery, Insilico Medicine, has completed an oversubscribed IPO in Hong Kong, raising around $293m.

News

MSD's $345m alliance with Variational, and other AI news

MSD signs $345m alliance with Variational AI, plus updates on AI in drug discovery projects from Bio Protocol, Dalton Tx, Virginia Tech, and Insilico.

Digital

The AI drug discovery race: Who’s leading the charge?

News

Insilico raises $110m for AI-designed drug pipeline

Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery operations.

News

Sanofi signs $1.2bn research alliance with AI specialist Ins...

Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 billion.

Insilico adds Servier to partnership roster with $888m deal

Insilico ends 2025 with $293m Hong Kong IPO

MSD's $345m alliance with Variational, and other AI news

The AI drug discovery race: Who’s leading the charge?

Insilico raises $110m for AI-designed drug pipeline

Sanofi signs $1.2bn research alliance with AI specialist Ins...

Sentynl gets first FDA approval for rare disease Menkes

How to meet your physicians where they are online

Insilico

Editor's Picks